Moderna Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall St set for higher open as AI stocks rise, oil slides
- Streamflation drives 39% of Americans to cancel streaming in 6 months
Moderna (MRNA) Extends Gain After Earnings, Up 6%
February 24, 2022 9:08 AM ESTModerna (NASDAQ: MRNA) Extends Gain After Earnings, Up 6%
Moderna (MRNA) Tops Q4 EPS by $1.39, Announces $3 billion share repurchase plan
February 24, 2022 7:00 AM ESTModerna (NASDAQ: MRNA) reported Q4 EPS of $11.29, $1.39 better than the analyst estimate of $9.90. Revenue for the quarter came in at $7.2 billion versus the consensus estimate of $6.78 billion.
Moderna announces a new $3 billion share repurchase planFor earnings history and earnings-related data on Moderna (MRNA) click here.
... More